Brown–Forman vs Johnson & Johnson

Side-by-side comparison of AI visibility scores, market position, and capabilities

Johnson & Johnson leads in AI visibility (82 vs 76)
Brown–Forman logo

Brown–Forman

LeaderConsumer Goods

Enterprise

Brown family-controlled spirits company; Jack Daniel's world's best-selling American whiskey; $4.2B FY2024 revenue; Woodford Reserve premium bourbon; EU tariff risk for ~60% international volumes.

AI VisibilityBeta
Overall Score
B76
Category Rank
#92 of 347
AI Consensus
76%
Trend
stable
Per Platform
ChatGPT
76
Perplexity
75
Gemini
81

About

Brown-Forman Corporation is one of the largest American-owned spirits and wine companies in the world, founded in 1870 by George Garvin Brown in Louisville, Kentucky, and still controlled by the Brown family, who own a majority of voting shares. The company trades on NYSE (BF-B for Class B shares) and generated approximately $4.2 billion in net sales for fiscal year 2024 (ending April 30, 2024) under CEO Lawson Whiting. Brown-Forman's crown jewel, Jack Daniel's Tennessee Whiskey, remains the world's best-selling American whiskey brand, complemented by a premium portfolio including Woodford Reserve (super-premium bourbon), Old Forester (the original bonded bourbon), Herradura and El Jimador tequilas, Benriach and GlenDronach single malt Scotches, and Diplomático rum.

Full profile
Johnson & Johnson logo

Johnson & Johnson

LeaderConsumer Goods

Health & Wellness

FY2024 Sales: $88.8B (+4.3%) | Net Profit: $14.1B (+5.6%) | EPS: $5.79 | Adjusted EPS: $9.98 | FY2025 Guidance: Operational Sales Growth 2.5-3.5%, Adj EPS $10.75-$10.95 (+8.7% midpoint)

AI VisibilityBeta
Overall Score
A82
Category Rank
#19 of 347
AI Consensus
74%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
77
Gemini
82

About

Johnson & Johnson is one of the world's largest healthcare companies, founded in 1886 by brothers Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson in New Brunswick, New Jersey, where the company remains headquartered. Established to manufacture ready-to-use surgical dressings at a time when post-operative infection was a leading cause of surgical mortality, J&J was built on the scientific principles of antiseptic surgery advocated by Joseph Lister. The company trades on the NYSE under ticker JNJ and has evolved over 135+ years from a consumer health products manufacturer into a focused MedTech and pharmaceutical enterprise, completing the spinoff of its consumer health segment (Kenvue) in 2023.\n\nJohnson & Johnson now operates through two segments: Innovative Medicine and MedTech. Innovative Medicine encompasses oncology, immunology, neuroscience, infectious disease, and cardiovascular pharmaceutical products — including blockbusters Darzalex, Stelara, Tremfya, and Rybrevant. The MedTech segment includes surgical robotics (Ottava platform in development), electrophysiology (Abiomed, Biosense Webster), orthopedics (DePuy Synthes), and surgery systems, serving hospitals and surgical centers worldwide. Following the Kenvue separation, J&J is a pure-play healthcare technology and pharmaceutical company with significantly higher growth and margin profiles than its historical blended consumer-pharma-medtech structure.\n\nJohnson & Johnson reported FY2024 sales of $88.8 billion, up 4.3% year over year, with net profit of $14.1 billion, up 5.6%. The company's Innovative Medicine segment continues to grow driven by oncology and immunology portfolio strength, while MedTech benefits from procedure volume recovery and robotic surgery adoption. J&J's scale, R&D pipeline depth, and global commercial infrastructure — spanning more than 60 countries — position it as one of the two or three most consequential healthcare enterprises globally, with a patent portfolio, clinical trial network, and regulatory expertise that are nearly impossible to replicate.

Full profile

AI Visibility Head-to-Head

76
Overall Score
82
#92
Category Rank
#19
76
AI Consensus
74
stable
Trend
stable
76
ChatGPT
83
75
Perplexity
77
81
Gemini
82
73
Claude
86
82
Grok
88

Key Details

Category
Enterprise
Health & Wellness
Tier
Leader
Leader
Entity Type
company
company

Capabilities & Ecosystem

Capabilities

Only Johnson & Johnson
Health & Wellness

Integrations

Only Brown–Forman
Brown–Forman is classified as company. Johnson & Johnson is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.